What constitutes clinical evidence for neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors?

What constitutes clinical evidence for neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors?

Item
http://www.wikidata.org/entity/Q31044171
Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse modelPre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's diseaseBeyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.Current and future therapy in Alzheimer's disease.Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately?Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease.Current perspectives on pharmacotherapy of Alzheimer's disease.Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy.Huprines for Alzheimer's disease drug development.Non human primate models for Alzheimer's disease-related research and drug discovery.Progress in the development of new drugs in Alzheimer's disease.Effects of thyroxin and donepezil on hippocampal acetylcholine content and syntaxin-1 and munc-18 expression in adult rats with hypothyroidism.Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model.Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease.
P2860

What constitutes clinical evidence for neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors?

Item
http://www.wikidata.org/entity/Q31044171
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
What constitutes clinical evid ...... the cholinesterase inhibitors?
@ast
What constitutes clinical evid ...... the cholinesterase inhibitors?
@en
type
label
What constitutes clinical evid ...... the cholinesterase inhibitors?
@ast
What constitutes clinical evid ...... the cholinesterase inhibitors?
@en
prefLabel
What constitutes clinical evid ...... the cholinesterase inhibitors?
@ast
What constitutes clinical evid ...... the cholinesterase inhibitors?
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
What constitutes clinical evid ...... the cholinesterase inhibitors?
@en
P2093
P304
P31
P356
10.1097/01.WAD.0000213805.66811.31
P407
P433
P478
P577
P698
P921